HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.

Attorneys general of New York, California, New Jersey and Massachusetts are asking the Food and Drug Administration (FDA) to expand access to the abortion pill and remove some “unnecessary ...

The states consider it a move to force the F.D.A. to review and acknowledge extensive research showing the pill’s safety. By Pam Belluck Pam Belluck covers reproductive health. In a strategy ...

The Food and Drug Administration will conduct a review of the abortion pill mifepristone following intense pressure from Sen. Josh Hawley (R-MO) and anti-abortion advocates to review updated ...

The popular Beats Pill Bluetooth speaker is now available for $99 at Walmart, marked down from its original price of $150. Available in four colors: black, gold, blue, and red.

Loud Women Fest has announced the first wave lineup for this year’s London, England festival. Bad Static, Be N!ce, Burry, Death Pill, Grace Savage, Hot Wife, I, Doris, Lesley Woods of Au Pairs, ...

They also showed that a low dose of carvedilol (e.g., <25 mg per day) is as effective as higher doses (e.g., 25–50 mg per day) at decreasing HVPG, with a lower risk of causing arterial hypotension.

The attorneys general of New York, California, Massachusetts and New Jersey asked the Food and Drug Administration to expand access to the abortion pill mifepristone, and remove what they view as ...

Maine will let abortion-pill prescribers keep their names off labels A new law will allow health-care providers to substitute their facility’s name for their own on prescriptions. June 3, 2025 ...

Food and Drug Administration Commissioner Martin Makary confirmed in a Monday letter to the Missouri senator that the agency will conduct a safety review of the abortion pill mifepristone.

The beta-blocker carvedilol is evaluated as a treatment for children with heart ... Pleasedo not use this form to submit personal or patient medical information or to report adverse drug events.

Ascletis Pharma’s acne pill has scored a phase 3 win, leading the Chinese biotech to claim the Sagimet Biosciences-sourced drug can hold its own against FDA-approved products like Seysara and ...